DK0973505T3 - Vandigt farmaceutisk præparat, der omfatter en aktiv ingrediens, som er meget tungt opløselig i vand - Google Patents
Vandigt farmaceutisk præparat, der omfatter en aktiv ingrediens, som er meget tungt opløselig i vandInfo
- Publication number
- DK0973505T3 DK0973505T3 DK98909460T DK98909460T DK0973505T3 DK 0973505 T3 DK0973505 T3 DK 0973505T3 DK 98909460 T DK98909460 T DK 98909460T DK 98909460 T DK98909460 T DK 98909460T DK 0973505 T3 DK0973505 T3 DK 0973505T3
- Authority
- DK
- Denmark
- Prior art keywords
- water
- pharmaceutical composition
- active ingredient
- aqueous pharmaceutical
- heavily soluble
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
- Y10S977/907—Liposome
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT97MI000363A IT1289939B1 (it) | 1997-02-20 | 1997-02-20 | Composizione farmaceutica acquosa comprendente un principio attivo altamente insolubile in acqua |
PCT/EP1998/000816 WO1998036735A1 (en) | 1997-02-20 | 1998-02-12 | Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0973505T3 true DK0973505T3 (da) | 2004-05-03 |
Family
ID=11376099
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98909460T DK0973505T3 (da) | 1997-02-20 | 1998-02-12 | Vandigt farmaceutisk præparat, der omfatter en aktiv ingrediens, som er meget tungt opløselig i vand |
Country Status (26)
Country | Link |
---|---|
US (1) | US6337087B1 (da) |
EP (1) | EP0973505B1 (da) |
JP (1) | JP4299369B2 (da) |
KR (1) | KR100515249B1 (da) |
CN (1) | CN1135969C (da) |
AR (1) | AR011682A1 (da) |
AT (1) | ATE257374T1 (da) |
AU (1) | AU740619B2 (da) |
BG (1) | BG64367B1 (da) |
CA (1) | CA2285985C (da) |
CZ (1) | CZ296700B6 (da) |
DE (1) | DE69821001T2 (da) |
DK (1) | DK0973505T3 (da) |
EA (1) | EA002281B1 (da) |
ES (1) | ES2213894T3 (da) |
GE (1) | GEP20022751B (da) |
HU (1) | HU225594B1 (da) |
IL (2) | IL131354A0 (da) |
IT (1) | IT1289939B1 (da) |
PL (1) | PL190987B1 (da) |
PT (1) | PT973505E (da) |
SK (1) | SK282905B6 (da) |
TR (1) | TR199901987T2 (da) |
UA (1) | UA63939C2 (da) |
WO (1) | WO1998036735A1 (da) |
ZA (1) | ZA981354B (da) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9804192D0 (sv) * | 1998-12-03 | 1998-12-03 | Scotia Lipidteknik Ab | New formulation |
US6075045A (en) * | 1999-04-28 | 2000-06-13 | Ajinomoto Co., Inc. | Method of treating paralysis of the extremities caused by cerebral infarction |
JP4894119B2 (ja) * | 2001-09-26 | 2012-03-14 | 日油株式会社 | 脂肪酸含有リポソーム分散液 |
US20040115226A1 (en) * | 2002-12-12 | 2004-06-17 | Wenji Li | Free-flowing solid formulations with improved bio-availability of poorly water soluble drugs and process for making the same |
AU2004206870A1 (en) * | 2003-01-17 | 2004-08-05 | Threshold Pharmaceuticals, Inc. | Treatment of benign prostatic hyperplasia using energolytic agents |
US20050238675A1 (en) * | 2004-04-26 | 2005-10-27 | Wenjie Li | Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications |
US8999292B2 (en) | 2012-05-01 | 2015-04-07 | Translatum Medicus Inc. | Methods for treating and diagnosing blinding eye diseases |
JP7326445B2 (ja) * | 2018-12-11 | 2023-08-15 | ディスラプション・ラブズ・インコーポレイテッド | 治療剤の送達のための組成物並びにその使用及び製造方法 |
CN111759807B (zh) * | 2019-04-01 | 2021-06-01 | 上海谷森医药有限公司 | 一种环孢素脂质体及其制备方法 |
CA3144861A1 (en) | 2019-06-25 | 2020-12-30 | Translatum Medicus, Inc. | Processes of making 2-((1-benzyl-1h-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1264668A (en) * | 1984-06-20 | 1990-01-23 | Pieter R. Cullis | Extrusion techniques for producing liposomes |
DE4038075C1 (en) * | 1990-11-29 | 1992-03-19 | B. Braun Melsungen Ag, 3508 Melsungen, De | Encapsulating solid or liq. lipophilic agents - comprises mixing hydration medium with phospholipid increasing temp. to above soln. phase change temp. and adding remaining medium |
IT1254995B (it) * | 1992-06-24 | 1995-10-11 | Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani | |
AT396755B (de) * | 1992-07-09 | 1993-11-25 | Oesko Gmbh | Verfahren zum reinigen eines rauchgasstromes mit hilfe einer waschflüssigkeit |
FR2716110B1 (fr) * | 1994-02-16 | 1996-04-05 | Roussel Uclaf | Compositions cosmétiques ou pharmaceutiques comprenant des liposomes. |
DE4430593C2 (de) * | 1994-08-20 | 1999-01-14 | Max Delbrueck Centrum | Verfahren zur Herstellung von Liposomal verkapseltem Taxol |
AU6047996A (en) * | 1995-06-07 | 1996-12-30 | Nexstar Pharmaceuticals, Inc. | Liposomal cyclosporin formulations as agents for immunosuppr ession and multiple drug resistant indications |
-
1997
- 1997-02-20 IT IT97MI000363A patent/IT1289939B1/it active IP Right Grant
-
1998
- 1998-02-12 EP EP98909460A patent/EP0973505B1/en not_active Expired - Lifetime
- 1998-02-12 US US09/367,699 patent/US6337087B1/en not_active Expired - Lifetime
- 1998-02-12 ES ES98909460T patent/ES2213894T3/es not_active Expired - Lifetime
- 1998-02-12 DE DE69821001T patent/DE69821001T2/de not_active Expired - Lifetime
- 1998-02-12 DK DK98909460T patent/DK0973505T3/da active
- 1998-02-12 AT AT98909460T patent/ATE257374T1/de active
- 1998-02-12 CZ CZ0292699A patent/CZ296700B6/cs not_active IP Right Cessation
- 1998-02-12 PL PL335208A patent/PL190987B1/pl unknown
- 1998-02-12 PT PT98909460T patent/PT973505E/pt unknown
- 1998-02-12 JP JP53622798A patent/JP4299369B2/ja not_active Expired - Fee Related
- 1998-02-12 GE GEAP19984992A patent/GEP20022751B/en unknown
- 1998-02-12 CA CA002285985A patent/CA2285985C/en not_active Expired - Fee Related
- 1998-02-12 HU HU0000910A patent/HU225594B1/hu not_active IP Right Cessation
- 1998-02-12 AU AU63987/98A patent/AU740619B2/en not_active Ceased
- 1998-02-12 EA EA199900750A patent/EA002281B1/ru not_active IP Right Cessation
- 1998-02-12 SK SK1111-99A patent/SK282905B6/sk not_active IP Right Cessation
- 1998-02-12 TR TR1999/01987T patent/TR199901987T2/xx unknown
- 1998-02-12 CN CNB98802733XA patent/CN1135969C/zh not_active Expired - Fee Related
- 1998-02-12 IL IL13135498A patent/IL131354A0/xx unknown
- 1998-02-12 KR KR10-1999-7007539A patent/KR100515249B1/ko not_active IP Right Cessation
- 1998-02-12 WO PCT/EP1998/000816 patent/WO1998036735A1/en active IP Right Grant
- 1998-02-18 ZA ZA981354A patent/ZA981354B/xx unknown
- 1998-02-20 AR ARP980100755A patent/AR011682A1/es active IP Right Grant
- 1998-12-02 UA UA99095151A patent/UA63939C2/uk unknown
-
1999
- 1999-08-11 IL IL131354A patent/IL131354A/en not_active IP Right Cessation
- 1999-09-16 BG BG103739A patent/BG64367B1/bg unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20002217L (no) | Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler | |
DE69942921D1 (de) | Osmotische Dosierungsform mit verlängerter Wirkstoffabgabe | |
NO20026037L (no) | Sötvareprodukt som inneholder aktive bestanddeler | |
MA26548A1 (fr) | Compositions pharmaceutiques topiques contenant des derives de resorcinol. | |
DK0769965T3 (da) | Vandige risperidonformuleringer | |
DE69001730D1 (de) | Pastenfoermige, waesserige pharmazeutische zusammensetzungen. | |
NO20034149L (no) | Legemidler inneholdende triazaspiro[5.5]undekanderivater som den aktive bestanddel | |
ZA200000603B (en) | Use of stilbene derivatives substituted in position 3, as deodrorant active agents in cosmetic compositions. | |
BR9704554B1 (pt) | utilizaÇço de lipÍdios complexos como adiÇÕes de estabilizaÇço para composiÇÕes farmacÊuticas de misturas de enzimas de digestço, composiÇÕes farmacÊuticas soléveis em Água e kit para preparaÇço de soluÇÕes aquosas. | |
DK0973505T3 (da) | Vandigt farmaceutisk præparat, der omfatter en aktiv ingrediens, som er meget tungt opløselig i vand | |
ATE316782T1 (de) | Neue orale formulierungen für 5-ht4 agonisten oder antagonisten | |
NO981522D0 (no) | Aminosyrederivater, deres fremstilling og anvendelse som endotelinantagonister | |
NO20006646L (no) | Aminosyrederivater og legemidler inneholdende de samme som aktiv bestanddel | |
IS2258B (is) | Setin tríasóló-pýridasín afleiða, lyfjasamsetningar gerðar úr henni | |
DE60001266D1 (de) | Betahistin-hältige formulierung mit kontrollierter wirkstofffreisetzung | |
DK0469440T3 (da) | Faste orale applikationsformer, der som aktivt stof indeholder ifosamid | |
NO985023L (no) | Sulfonamidsubstituerte benzopyranderivater, fremgangsmÕter for deres fremstilling, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene | |
NO20025028D0 (no) | 9-oksa-epotilonderivater, fremgangsmåte for fremstilling derav samt deres anvendelse i farmasöytiske preparater | |
DE50005076D1 (de) | Pharmazeutische, metamizol enthaltende brauseformulierung | |
NO20032035D0 (no) | Terapeutiske midler for heratokonjunktivitis sykdommer omfattende farnesyleddiksyre som aktiv ingrediens | |
SI0973505T1 (en) | Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water | |
NO20030474L (no) | Legemiddel mot demens inneholdende 2-aryl-8- oksodihydropurinderivater som aktiv bestanddel | |
DK1086695T3 (da) | Antivirale præparater omfattende yohimbin som aktivt princip | |
RU2002107045A (ru) | Дезинфицирующий состав для пропитки гигиенических салфеток | |
DK1236726T3 (da) | Triazaspiro[5.5]undecan-derivater og lægemidler indeholdende samme som den aktive bestanddel |